Ignite Creation Date:
2024-05-06 @ 7:39 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06085755
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-14
First Post:
2023-09-10
Brief Title:
Trastuzumab DeruxtecanT-DXd and Afatinib Combination in HER2-low Advanced Gastric Cancer
Sponsor:
Jeeyun Lee
Organization:
Samsung Medical Center
Organization Data
Organization:
Samsung Medical Center
Class:
OTHER
Study ID:
2023-09-015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jeeyun Lee
Lead Sponsor Class:
OTHER
Responsible Party:
Jeeyun Lee
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Samsung Medical Center
Old Name:
None
Old Organization:
None